234 related articles for article (PubMed ID: 6437000)
1. [Coagulation factors. Indications and applications].
Stampfli K; Hartmann S
Ther Umsch; 1984 Aug; 41(8):571-5. PubMed ID: 6437000
[No Abstract] [Full Text] [Related]
2. [Advances in the field of hemophilia therapy].
Loeliger EA; Veltkamp JJ
Ned Tijdschr Geneeskd; 1968 Sep; 112(36):1593-5. PubMed ID: 5680135
[No Abstract] [Full Text] [Related]
3. Recombinant blood clotting proteins for hemophilia therapy.
Limentani SA; Roth DA; Furie BC; Furie B
Semin Thromb Hemost; 1993; 19(1):62-72. PubMed ID: 8456325
[No Abstract] [Full Text] [Related]
4. [Substitution therapy of hemorrhagic diseases].
Haupt H
Anasthesiol Intensivmed Prax; 1975 Oct; 11(1):137-44. PubMed ID: 1225069
[No Abstract] [Full Text] [Related]
5. Recombinant antihemophilic factors.
Kurachi K
Biotechnology; 1991; 19():177-95. PubMed ID: 1786471
[No Abstract] [Full Text] [Related]
6. Hemophiliacs with inhibitors: therapeutic options.
Roberts HR
N Engl J Med; 1981 Sep; 305(13):757-8. PubMed ID: 6790992
[No Abstract] [Full Text] [Related]
7. [Concentrated antihemophilic globulin in the treatment of hemorrhagic syndromes].
Baklaja F; Cvetković V; Stajić M; Krivokapić L
Bilt Hematol Transfuz; 1976; 4(3):61-6. PubMed ID: 1008799
[TBL] [Abstract][Full Text] [Related]
8. Editorial: Factor VIII inhibitors.
Deykin D
N Engl J Med; 1974 Jul; 291(4):205. PubMed ID: 4834491
[No Abstract] [Full Text] [Related]
9. [Treatment of hemophiliacs with inhibitors].
Fujimaki M
Rinsho Ketsueki; 1985 Jul; 26(7):1059-68. PubMed ID: 3932719
[No Abstract] [Full Text] [Related]
10. [Substitution therapy with factor 8 and factor IX preparations].
Landbeck G
Hamatol Bluttransfus; 1968; 5():29-42. PubMed ID: 5729465
[No Abstract] [Full Text] [Related]
11. Transfusion therapy in congenital coagulopathies.
Lusher JM
Hematol Oncol Clin North Am; 1994 Dec; 8(6):1167-80. PubMed ID: 7860443
[TBL] [Abstract][Full Text] [Related]
12. [Blood plasma fractions for the management of coagulation disorders: 3. The P.P.S.B. fraction].
Richter K; Klingenberg K; Reinecke D
Z Gesamte Inn Med; 1968 Jan; 23(1):18-21. PubMed ID: 5662427
[No Abstract] [Full Text] [Related]
13. Transfusion support for haemophiliacs.
Allain JP
Clin Haematol; 1984 Feb; 13(1):99-117. PubMed ID: 6426835
[No Abstract] [Full Text] [Related]
14. [Substitution therapy of coagulopathies].
Beeser H; Egli H
Infusionstherapie (1973); 1974 Aug; 1(6):447-53. PubMed ID: 4466806
[No Abstract] [Full Text] [Related]
15. Use of blood products and factor concentrates for coagulation therapy.
Fritsma MG
Clin Lab Sci; 2003; 16(2):115-9. PubMed ID: 12757192
[TBL] [Abstract][Full Text] [Related]
16. The management of patients with bleeding disorders.
Wyld PJ; Dawson KP
N Z Med J; 1984 Feb; 97(750):118-9. PubMed ID: 6424072
[No Abstract] [Full Text] [Related]
17. Current concepts in diagnosis and management of hemophilia.
Aledort LM
Hosp Pract (Off Ed); 1982 Oct; 17(10):77-84, 89-92. PubMed ID: 6811410
[No Abstract] [Full Text] [Related]
18. [Inhibitor hemophilia in oral surgery].
Schulz S
Zahn Mund Kieferheilkd Zentralbl; 1984; 72(8):824-8. PubMed ID: 6240865
[No Abstract] [Full Text] [Related]
19. Surgery in haemophilic patients with inhibitors.
Rodriguez-Merchan EC
Haemophilia; 2004 Sep; 10 Suppl 2():1-2. PubMed ID: 15385039
[No Abstract] [Full Text] [Related]
20. New alternatives and strategies in the treatment of inhibitors.
Hoyer LW
Prog Clin Biol Res; 1984; 150():367-72. PubMed ID: 6431440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]